US5686073AExpiredUtility
Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
Est. expiryMay 23, 2010(expired)· nominal 20-yr term from priority
A61K 39/00C07K 2317/34G01N 33/6887G01N 2800/2885C07K 14/4708C07K 14/4707G01N 2800/2878C07K 16/18G01N 33/6896C07K 14/705A61K 38/00C07K 16/28
62
PatentIndex Score
31
Cited by
36
References
6
Claims
Abstract
Disclosed are methods for the preparation of polyclonal and monoclonal antibodies which bind specifically to a 43 kDa dystrophin-associated. The molecular weight of the 43 kDa protein is determined by electrophoretic separation under denaturing conditions, followed by transfer to a solid support and staining with wheat germ agglutinin. The method includes a step in which the peptide PKNMTPYRSPPPYVP (SEQ ID NO: 15) is administered to stimulate an immune response. Also disclosed are polyclonal and monoclonal antibodies which bind specifically to the 43 kDa dystrophin-associated protein.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method for producing a polyclonal antibody which binds specifically to the 43 kDa dystrophin-associated protein, the molecular weight of the protein being determined by electrophoretic separation under denaturing conditions, transfer to a solid support and staining with wheat germ agglutinin, the method comprising: a) providing the peptide PKNMTPYRSPPPYVP (SEQ ID NO: 15); b) administering the peptide to a mammal under conditions appropriate for the stimulation of an immune response; and c) isolating the polyclonal antibody from the mammal.
2. The method of claim 1 wherein the peptide is produced synthetically.
3. A method for producing a monoclonal antibody which binds specifically to the 43 kDa dystrophin-associated protein, the molecular weight of the protein being determined by electrophoretic separation under denaturing conditions, transfer to a solid support and staining with wheat germ agglutinin, the method comprising: a) providing the peptide PKNMTPYRSPPPYVP (SEQ ID NO: 15); b) administering the peptide to a mammal under conditions appropriate for the stimulation of an immune response; c) isolating antibody producing cells from the mammal; d) fusing the antibody producing cells with immortalizing cells to produce a hybridoma cell line; and e) screening the resulting hybridoma cell line to identify cell lines secreting antibody having the desired specificity.
4. The method of claim 3 wherein the peptide is produced synthetically.
5. An immunogenic peptide PKNMTPYRSPPPYVP (SEQ ID NO: 15) which, in the immunization of a mammal, stimulates the production of antibodies which bind specifically to the 43 kDa dystrophin-associated protein, the molecular weight of the protein being determined by electrophoretic separation under denaturing conditions, transfer to a solid support and staining with wheat germ agglutinin.
6. The immunogenic peptide of claim 5, which is produced synthetically.Join the waitlist — get patent alerts
Track US5686073A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.